MedTrace Logo

Honey Versus Povidone-iodine on Laceration Wounds

NCT03641053 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2018-08-29

No results posted yet for this study

Summary

This study evaluates healing time in usage of honey and povidone-iodine over paraffin gauze as dressings in the treatment of acute laceration wounds. In Indonesia, especially in rural area, where most of the resources is limited and modern dressings are expensive and hard-to-find. The investigators tried to find an alternative which was easier to find and could act as a substitute of modern wound dressing.

The hypothesis of this study is honey and povidone-iodine could be a good substitute (or equal to) to paraffin gauze on acute laceration wounds.

Honey is chosen because of its versatility and already well-known to be used as a chronic wound dressing. Povidone-iodine was chosen as another alternative because it is still one of the most used substance in rural area as a wound dressing, but there is not enough study to support the usage of this substance. Paraffin gauze was chosen as a representative of modern wound dressing because it fulfilled the standard of wound dressing on acute wound, which is non-adherent and also moist.

Conditions

  • Laceration Face
  • Wound Heal
  • Wounds and Injuries
  • Laceration Arm
  • Laceration of Leg

Interventions

OTHER

Honey

Substance is given topically after the wound has been sutured

OTHER

Povidone-iodine

Substance is given topically after the wound has been sutured

OTHER

Paraffin gauze

Substance is given topically after the wound has been sutured

Sponsors & Collaborators

  • S.K. Lerik General Hospital

    lead OTHER

Principal Investigators

  • Kevin L Suryadinata, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-29
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03641053 on ClinicalTrials.gov